Veeva Systems Partners with AOP Health to Enhance Rare Disease and Critical Care Solutions

### Veeva Systems Fuels AOP Health's Commitment to Rare Disease and Critical Care Solutions

On March 10, 2026, Veeva Systems announces a pivotal collaboration with AOP Health, a notable player in integrated therapies for rare diseases and critical care. Under this partnership, AOP Health embraces the Veeva Vault Platform aimed at streamlining its operational framework. This strategic move is particularly significant as AOP Health, with almost three decades of experience, aspires to enhance its capabilities in developing essential treatments for patients with severe and rare conditions. The integration of Veeva’s Development Cloud, Quality Cloud, Commercial Cloud, and Data Cloud will assist AOP Health in breaking down operational silos and expediting the delivery of medicines to a global patient population.

AOP Health’s Vice President of Digital, Data, and IT, Bernard Seiser, underscores the company's longstanding commitment to improving patient outcomes through innovative therapies. By adopting Veeva’s unified technological platform, AOP aims to bolster collaboration among its various teams, including clinical, regulatory, quality, and commercial divisions. This optimization is designed to drive efficiencies in operations while maintaining high standards of quality and compliance essential in the biopharmaceutical landscape. The collaboration not only aligns with AOP’s motto of "Needs. Science. Trust," but also emphasizes their mission to address unmet medical needs in the realms of rare diseases and intensive care.

Reflecting on the partnership, Rik van Mol, Senior Vice President of Development Cloud Strategy at Veeva, notes that AOP Health’s cloud-connected approach is vital for driving operational efficiency and accelerating growth. As AOP Health continues to leverage digital tools, the alliance is set to enhance patient care through enhanced insights and collaborative endeavors in research and commercialization efforts. This integration demonstrates how Veeva’s innovative cloud solutions can empower biopharmaceutical firms to transform their service delivery in critical therapeutic areas, ultimately leading to improved healthcare outcomes.

In addition to this collaboration, Veeva recently acquired Ostro, a leading brand engagement platform within the life sciences sector, for approximately $100 million. This acquisition aims to enhance how healthcare professionals and patients engage with reliable information via an AI-driven chat interface. Ostro is expected to operate independently while developing integrations with Veeva's Commercial Cloud applications, facilitating seamless communication and enriched customer interactions. This initiative signifies Veeva's commitment to advancing the role of technology in healthcare, reinforcing its position as a pioneer in delivering comprehensive cloud solutions for the life sciences industry.

As Veeva and AOP Health embark on this collaborative journey, the industry watches closely, recognizing the potential transformative impact on the management and treatment of rare diseases and critical health conditions.